168 related articles for article (PubMed ID: 33466307)
1. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy.
Cusumano D; Boldrini L; Yadav P; Casà C; Lee SL; Romano A; Piras A; Chiloiro G; Placidi L; Catucci F; Votta C; Mattiucci GC; Indovina L; Gambacorta MA; Bassetti M; Valentini V
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33466307
[TBL] [Abstract][Full Text] [Related]
2. A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Chiloiro G; Boldrini L; Preziosi F; Cusumano D; Yadav P; Romano A; Placidi L; Lenkowicz J; Dinapoli N; Bassetti MF; Gambacorta MA; Valentini V
Front Oncol; 2022; 12():831712. PubMed ID: 35280799
[TBL] [Abstract][Full Text] [Related]
3. Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation.
Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Romano A; De Luca V; Votta C; Barbaro B; Gambacorta MA; Bassetti MF; Yang Y; Indovina L; Valentini V
Phys Med; 2021 Apr; 84():186-191. PubMed ID: 33901863
[TBL] [Abstract][Full Text] [Related]
4. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach.
Boldrini L; Cusumano D; Chiloiro G; Casà C; Masciocchi C; Lenkowicz J; Cellini F; Dinapoli N; Azario L; Teodoli S; Gambacorta MA; De Spirito M; Valentini V
Radiol Med; 2019 Feb; 124(2):145-153. PubMed ID: 30374650
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of Delta-Radiomics Texture Features in 0.35 Tesla Magnetic Resonance Setup Images Acquired During Stereotactic Ablative Radiotherapy of Pancreatic Cancer.
Simpson G; Jin W; Spieler B; Portelance L; Mellon E; Kwon D; Ford JC; Dogan N
Front Oncol; 2022; 12():807725. PubMed ID: 35515129
[TBL] [Abstract][Full Text] [Related]
7. External Validation of Early Regression Index (ERI
Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Broggi S; Romano A; Mori M; Barbaro B; Azario L; Gambacorta MA; De Spirito M; Bassetti MF; Yang Y; Fiorino C; Valentini V
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1347-1356. PubMed ID: 32758641
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of delta radiomics-based pCR prediction for rectal cancer patients treated with magnetic resonance-guided adaptive radiotherapy.
Wu J; Xiao J; Li Y; Wu F; Peng Q; Li C; Tang B; Orlandini LC
Front Oncol; 2023; 13():1230519. PubMed ID: 38074653
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
[TBL] [Abstract][Full Text] [Related]
10. Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer.
Tomaszewski MR; Latifi K; Boyer E; Palm RF; El Naqa I; Moros EG; Hoffe SE; Rosenberg SA; Frakes JM; Gillies RJ
Radiat Oncol; 2021 Dec; 16(1):237. PubMed ID: 34911546
[TBL] [Abstract][Full Text] [Related]
11. An investigation of machine learning methods in delta-radiomics feature analysis.
Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
[TBL] [Abstract][Full Text] [Related]
12. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
13. Fractal-Based Radiomic Approach to Tailor the Chemotherapy Treatment in Rectal Cancer: A Generating Hypothesis Study.
Di Dio C; Chiloiro G; Cusumano D; Catucci F; Boldrini L; Romano A; Meldolesi E; Marazzi F; Corvari B; Barbaro B; Manfredi R; Valentini V; Gambacorta MA
Front Oncol; 2021; 11():774413. PubMed ID: 34956893
[TBL] [Abstract][Full Text] [Related]
14. MRI-based delta-radiomic features for prediction of local control in liver lesions treated with stereotactic body radiation therapy.
Jin WH; Simpson GN; Dogan N; Spieler B; Portelance L; Yang F; Ford JC
Sci Rep; 2022 Nov; 12(1):18631. PubMed ID: 36329116
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
16. MR-Based Radiomics Nomogram of Cervical Cancer in Prediction of the Lymph-Vascular Space Invasion preoperatively.
Li Z; Li H; Wang S; Dong D; Yin F; Chen A; Wang S; Zhao G; Fang M; Tian J; Wu S; Wang H
J Magn Reson Imaging; 2019 May; 49(5):1420-1426. PubMed ID: 30362652
[TBL] [Abstract][Full Text] [Related]
17. Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs.
Gao Y; Kalbasi A; Hsu W; Ruan D; Fu J; Shao J; Cao M; Wang C; Eilber FC; Bernthal N; Bukata S; Dry SM; Nelson SD; Kamrava M; Lewis J; Low DA; Steinberg M; Hu P; Yang Y
Phys Med Biol; 2020 Aug; 65(17):175006. PubMed ID: 32554891
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
19. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Prediction of Adaptive Radiation Therapy Eligibility Using MRI-Based Radiomics for Advanced Nasopharyngeal Carcinoma Patients.
Yu TT; Lam SK; To LH; Tse KY; Cheng NY; Fan YN; Lo CL; Or KW; Chan ML; Hui KC; Chan FC; Hui WM; Ngai LK; Lee FK; Au KH; Yip CW; Zhang Y; Cai J
Front Oncol; 2019; 9():1050. PubMed ID: 31681588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
